Terminated OBSERVATIONAL NCT00533572

Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer

Sponsor: Stanford University

Conditions Epidermolysis Bullosa Dystrophica

Updated 11 times since 2017 Last updated: May 22, 2015 Started: Aug 31, 2007 Primary completion: Aug 31, 2008 Completion: Aug 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study was suspended until FDA approved the IND. Study has since been terminated and a new screening process has been implemented.

Other terminated trials from Stanford University

See all terminations from Stanford University

A observational or N/A phase clinical study on Epidermolysis Bullosa Dystrophica, this trial is terminated or withdrawn. The trial is conducted by Stanford University and has accumulated 11 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Dec 2021 — Jul 2024 [monthly]

Terminated
Jan 2021 — Dec 2021 [monthly]

Terminated
Nov 2020 — Jan 2021 [monthly]

Terminated

▶ Show 6 earlier versions

Jun 2018 — Nov 2020 [monthly]

Terminated
May 2018 — Jun 2018 [monthly]

Terminated
Apr 2018 — May 2018 [monthly]

Terminated

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Terminated NA
Feb 2017 — Aug 2017 [monthly]

Terminated NA
Jan 2017 — Feb 2017 [monthly]

Terminated NA

First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stanford University

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stanford, United States